PATENT CLAIM ANALYSIS

Application Number: 15907057
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "180000"]

Abstract:
Disclosed are aqueous pharmaceutical compositions which provide sustained released delivery of corticosteroid compounds. The pharmaceutical composition comprises a soluble corticosteroid and at least one viscosity enhancing agent. Also provided are methods for using the pharmaceutical compositions in an epidural injection, intra-articular injection, or an intra-lesional injection.

Claim (Index 7):
The method of  claim 1 , wherein the soluble corticosteroid is dexamethasone sodium phosphate and the at least one viscosity enhancing agent is sodium hyaluronate,\n wherein the molecular weight of the sodium hyaluronate is between 1.0 MDa and 2.0 MDa, and the concentration of the sodium hyaluronate is about 1.25% w/v.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 88.0
- Lexical Diversity: 1.275
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15545204', '14162625', '15043750', '15818089', '11828561']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7641994212679128
- 35 USC 102 Novelty (BERT): 0.6635453565976657
- Combined Prediction Score: 0.7541340148008882
- Mean Citation Score: 362.791794
- Max Citation Score: 654.7074
- Similarity Product: 620.4936130331755

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test